Elnaggar, Mohamed G.
Mosad, Eman
Makboul, Ahmed
Shafik, Engy Adel
Funding for this research was provided by:
Assiut University
Article History
Received: 9 June 2022
Accepted: 12 September 2022
First Online: 5 October 2022
Declarations
:
: The Ethical Committee of South Egypt Cancer Institute, Assiut University approved our study (SECI-IRB IORG0006563—Registration Number: 444). Before enrollment in our study, the participants were asked to provide written informed consent. The study was registered on ClinicalTrials.gov (NCT Number: NCT03719183). Our study conforms to provisions of the Declaration of Helsinki.
: Written informed consent for publication of their clinical details was obtained from the patient/parent/guardian/ relative of the patient. A copy of the consent form is available for review by the Editor of this journal.
: The authors declare that they have no competing interests.